325
Views
20
CrossRef citations to date
0
Altmetric
UrologyOriginal Articles

Managing localized prostate cancer by radical prostatectomy or watchful waiting: Cost analysis of a randomized trial (SPCG-4)

, , , , , , & show all
Pages 177-183 | Received 18 Aug 2010, Accepted 16 Nov 2010, Published online: 25 Jan 2011

References

  • Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225–49.
  • Kvale R, Auvinen A, Adami HO, Klint A, Hernes E, Moller B, Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst 2007;99:1881–7.
  • Draisma G, Etzioni R, Tsodikov A, Mariotto A, Wever E, Gulati R, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst 2009;101:374–83.
  • Johansson JE, Andren O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Natural history of early, localized prostate cancer. JAMA 2004;291:2713–9.
  • Klotz L. Active surveillance for prostate cancer: trials and tribulations. World J Urol 2008;26:437–42.
  • Bill-Axelson A, Holmberg L, Filen F, Ruutu M, Garmo H, Busch C, Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian Prostate Cancer Group-4 randomized trial. J Natl Cancer Inst 2008;100:1144–54.
  • Steinek G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlen BJ, Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002;347:790–6.
  • Johansson E, Bill-Axelson A, Holmberg L, Onelov E, Johansson JE, Steineck G. Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trial. Eur Urol 2009;55:422–30.
  • Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000;320:1197–200.
  • Sennfalt K, Carlsson P, Thorfinn J, Frisk J, Henriksson M, Varenhorst E. Technological changes in the management of prostate cancer result in increased healthcare costs – a retrospective study in a defined Swedish population. Scand J Urol Nephrol 2003;37:226–31.
  • Penson DF, Schonfeld WH, Flanders SC, Henke CJ, Warolin KL, Carroll PR, Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database. Urology 2001;57:499–503.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.